Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Cue Biopharma revenue
Cue Biopharma's revenue is $9.3 million.
What is Cue Biopharma's revenue?
- Cue Biopharma has 46 employees, and the revenue per employee ratio is $201,891.
- Cue Biopharma's peak quarterly revenue was $8.3M in 2021(q4).
- Cue Biopharma peak revenue was $14.9M in 2021.
- Cue Biopharma annual revenue for 2023 was 5.5M, 340.96% growth from 2022.
- Cue Biopharma annual revenue for 2024 was 9.3M, 69.16% growth from 2023.
- Cue Biopharma's revenue growth from 2018 to 2024 is 712.79%.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Cue Biopharma historical revenue
Cue Biopharma's peak revenue was $14.9M in 2021. The peak quarterly revenue was $8.3M in 2021(q4).
Cue Biopharma's revenue increased from $1.1m in 2018 to $9.3M currently. That's a 712.79% change in annual revenue.
Cue Biopharma annual revenue
Cue Biopharma annual revenue over time
| Fiscal year / year | Cue Biopharma revenue |
|---|---|
| 2018 | $1.1M |
| 2019 | $3.5M |
| 2020 | $3.2M |
| 2021 | $14.9M |
| 2022 | $1.2M |
| 2023 | $5.5M |
| 2024 | $9.3M |
How accurately did Cue Biopharma's revenue projections match actual performance?
Cue Biopharma annual growth
Cue Biopharma saw the greatest revenue growth in 2021, when revenue increased by 373.68%.
Cue Biopharma had the lowest revenue growth in 2022, when revenue changed by -91.67%.
Cue Biopharma annual growth rate over time
| Year | Cue Biopharma growth |
|---|---|
| 2019 | 203%↑ |
| 2020 | -9%↓ |
| 2021 | 374%↑ |
| 2022 | -92%↓ |
| 2023 | 341%↑ |
| 2024 | 69%↑ |
Cue Biopharma quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Cue Biopharma quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | $172,000 | $449,000 | $330,604 |
| 2019 | $370,000 | $1.1M | $984,000 | $1.0M |
| 2020 | $900,000 | $1.1M | $704,000 | $475,325 |
| 2021 | $1.6M | $2.7M | $2.4M | $8.3M |
| 2022 | $1.0M | $26,000 | $68,000 | $151,000 |
| 2023 | $187,000 | $1.4M | $2.1M | $1.8M |
| 2024 | $1.7M | $2.7M | $3.3M | $1.6M |
Cue Biopharma jobs nearby
Do you work at Cue Biopharma?
Is Cue Biopharma transparent about its revenue structure?
Cue Biopharma financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 46 |
| Date Founded | 2014 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 1 |
| Revenue | $9.3M |
| Net Income | -$53,010,382 |
| Tax Rate | -0.0% |
| Total Assets | $91,283,000 |
| Ticker | CUE |
Cue Biopharma jobs you might like
Cue Biopharma financing
Cue Biopharma received early financing of $10.0M on 2015-01-03.
| Series | Round size | Date |
|---|---|---|
| Series A | $10M | 01/2015 |
| Series B | $16.4M | 01/2017 |
Cue Biopharma investors
| Investors | Security type |
|---|---|
| MDB Capital Group | Series A |
| MDB Capital Group | Series B |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Cue Biopharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cue Biopharma. The employee data is based on information from people who have self-reported their past or current employments at Cue Biopharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cue Biopharma. The data presented on this page does not represent the view of Cue Biopharma and its employees or that of Zippia.
Cue Biopharma may also be known as or be related to CUE BIOPHARMA, INC., Cue Biopharma, Cue Biopharma Inc and Cue Biopharma, Inc.